Glenn C. Rowe, Ph.D. - Publications

2007 Yale University, New Haven, CT 
Molecular Biology, Cell Biology

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Sato K, Idelevich A, Nagano K, Rowe GC, Gori F, Baron R. Hypothalamic ΔFosB prevents age-related metabolic decline and functions via SNS. Aging. PMID 28121620 DOI: 10.18632/aging.101157  0.32
2016 Iacovelli J, Rowe GC, Khadka A, Diaz-Aguilar D, Spencer C, Arany Z, Saint-Geniez M. PGC-1α Induces Human RPE Oxidative Metabolism and Antioxidant Capacity. Investigative Ophthalmology & Visual Science. 57: 1038-51. PMID 26962700 DOI: 10.1167/iovs.15-17758  0.32
2014 Rowe GC, Raghuram S, Jang C, Nagy JA, Patten IS, Goyal A, Chan MC, Liu LX, Jiang A, Spokes KC, Beeler D, Dvorak H, Aird WC, Arany Z. PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Circulation Research. 115: 504-17. PMID 25009290 DOI: 10.1161/CIRCRESAHA.115.303829  0.32
2014 Rowe GC, Safdar A, Arany Z. Running forward: new frontiers in endurance exercise biology. Circulation. 129: 798-810. PMID 24550551 DOI: 10.1161/CIRCULATIONAHA.113.001590  0.32
2014 Thom R, Rowe GC, Jang C, Safdar A, Arany Z. Hypoxic induction of vascular endothelial growth factor (VEGF) and angiogenesis in muscle by truncated peroxisome proliferator-activated receptor γ coactivator (PGC)-1α. The Journal of Biological Chemistry. 289: 8810-7. PMID 24505137 DOI: 10.1074/jbc.M114.554394  0.32
2014 Chan MC, Rowe GC, Raghuram S, Patten IS, Farrell C, Arany Z. Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin. Skeletal Muscle. 4: 2. PMID 24447845 DOI: 10.1186/2044-5040-4-2  0.32
2014 Rowe GC, Arany Z. Genetic models of PGC-1 and glucose metabolism and homeostasis. Reviews in Endocrine & Metabolic Disorders. 15: 21-9. PMID 24057597 DOI: 10.1007/s11154-013-9273-5  0.32
2013 Haq R, Shoag J, Andreu-Perez P, Yokoyama S, Edelman H, Rowe GC, Frederick DT, Hurley AD, Nellore A, Kung AL, Wargo JA, Song JS, Fisher DE, Arany Z, Widlund HR. Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. Cancer Cell. 23: 302-15. PMID 23477830 DOI: 10.1016/j.ccr.2013.02.003  0.32
2013 Shoag J, Haq R, Zhang M, Liu L, Rowe GC, Jiang A, Koulisis N, Farrel C, Amos CI, Wei Q, Lee JE, Zhang J, Kupper TS, Qureshi AA, Cui R, et al. PGC-1 coactivators regulate MITF and the tanning response. Molecular Cell. 49: 145-57. PMID 23201126 DOI: 10.1016/j.molcel.2012.10.027  0.32
2012 Rowe GC, El-Khoury R, Patten IS, Rustin P, Arany Z. PGC-1α is dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle. Plos One. 7: e41817. PMID 22848618 DOI: 10.1371/journal.pone.0041817  0.32
2012 Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 485: 333-8. PMID 22596155 DOI: 10.1038/nature11040  0.32
2012 Rowe GC, Vialou V, Sato K, Saito H, Yin M, Green TA, Lotinun S, Kveiborg M, Horne WC, Nestler EJ, Baron R. Energy expenditure and bone formation share a common sensitivity to AP-1 transcription in the hypothalamus. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 1649-58. PMID 22461201 DOI: 10.1002/jbmr.1618  0.32
2012 Finley LW, Lee J, Souza A, Desquiret-Dumas V, Bullock K, Rowe GC, Procaccio V, Clish CB, Arany Z, Haigis MC. Skeletal muscle transcriptional coactivator PGC-1α mediates mitochondrial, but not metabolic, changes during calorie restriction. Proceedings of the National Academy of Sciences of the United States of America. 109: 2931-6. PMID 22308395 DOI: 10.1073/pnas.1115813109  0.32
2011 McDermott-Roe C, Ye J, Ahmed R, Sun XM, Serafín A, Ware J, Bottolo L, Muckett P, Cañas X, Zhang J, Rowe GC, Buchan R, Lu H, Braithwaite A, Mancini M, et al. Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature. 478: 114-8. PMID 21979051 DOI: 10.1038/nature10490  0.32
2011 Tran M, Tam D, Bardia A, Bhasin M, Rowe GC, Kher A, Zsengeller ZK, Akhavan-Sharif MR, Khankin EV, Saintgeniez M, David S, Burstein D, Karumanchi SA, Stillman IE, Arany Z, et al. PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. The Journal of Clinical Investigation. 121: 4003-14. PMID 21881206 DOI: 10.1172/JCI58662  0.32
2011 Rowe GC, Jang C, Patten IS, Arany Z. PGC-1β regulates angiogenesis in skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism. 301: E155-63. PMID 21364124 DOI: 10.1152/ajpendo.00681.2010  0.32
2010 Rowe GC, Jiang A, Arany Z. PGC-1 coactivators in cardiac development and disease. Circulation Research. 107: 825-38. PMID 20884884 DOI: 10.1161/CIRCRESAHA.110.223818  0.32
2010 Lewis GD, Farrell L, Wood MJ, Martinovic M, Arany Z, Rowe GC, Souza A, Cheng S, McCabe EL, Yang E, Shi X, Deo R, Roth FP, Asnani A, Rhee EP, et al. Metabolic signatures of exercise in human plasma. Science Translational Medicine. 2: 33ra37. PMID 20505214 DOI: 10.1126/scitranslmed.3001006  0.32
2009 Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe GC, Sawada N, Raghuram S, Arany Z. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 106: 21401-6. PMID 19966219 DOI: 10.1073/pnas.0909131106  0.32
2009 Wu M, Hesse E, Morvan F, Zhang JP, Correa D, Rowe GC, Kiviranta R, Neff L, Philbrick WM, Horne WC, Baron R. Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo. Bone. 44: 528-36. PMID 19095088 DOI: 10.1016/j.bone.2008.11.011  0.32
2009 Rowe GC, Choi CS, Neff L, Horne WC, Shulman GI, Baron R. Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice. Endocrinology. 150: 135-43. PMID 18772235 DOI: 10.1210/en.2008-0678  0.32
2008 Sabatakos G, Rowe GC, Kveiborg M, Wu M, Neff L, Chiusaroli R, Philbrick WM, Baron R. Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 23: 584-95. PMID 18433296 DOI: 10.1359/jbmr.080110  0.32
Show low-probability matches.